Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism

CONTEXT: Inhibitors of the protease neprilysin (NEP) are used for treating heart failure, but are also linked to improvements in metabolism. NEP may cleave proglucagon-derived peptides, including the glucose and amino acid (AA)-regulating hormone glucagon. Studies investigating NEP inhibition on glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjeldsen, Sasha A S, Hansen, Lasse H, Esser, Nathalie, Mongovin, Steve, Winther-Sørensen, Marie, Galsgaard, Katrine D, Hunt, Jenna E, Kissow, Hannelouise, Ceutz, Frederik R, Terzic, Dijana, Mark, Peter D, Plomgaard, Peter, Goetze, Jens P, Goossens, Gijs H, Blaak, Ellen E, Deacon, Carolyn F, Rosenkilde, Mette M, Zraika, Sakeneh, Holst, Jens J, Wewer Albrechtsen, Nicolai J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317634/
https://www.ncbi.nlm.nih.gov/pubmed/34337276
http://dx.doi.org/10.1210/jendso/bvab084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317634/
https://www.ncbi.nlm.nih.gov/pubmed/34337276
http://dx.doi.org/10.1210/jendso/bvab084

Ejemplares similares